Prostate-specific antigen and prostate cancer: Prediction, detection and monitoring Review uri icon

Overview

MeSH Major

  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • Testing for prostate-specific antigen (PSA) has profoundly affected the diagnosis and treatment of prostate cancer. PSA testing has enabled physicians to detect prostate tumours while they are still small, low-grade and localized. This very ability has, however, created controversy over whether we are now diagnosing and treating insignificant cancers. PSA testing has also transformed the monitoring of treatment response and detection of disease recurrence. Much current research is directed at establishing the most appropriate uses of PSA testing and at developing methods to improve on the conventional PSA test.

publication date

  • April 2008

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1038/nrc2351

PubMed ID

  • 18337732

Additional Document Info

start page

  • 268

end page

  • 78

volume

  • 8

number

  • 4